Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nihad A M Tamimi

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Saudi Journal of Kidney Diseases and Transplantation : an Official Publication of the Saudi Center for Organ Transplantation, Saudi Arabia|August 8, 2007
Resistant hypertension: a methodological approach to diagnosis and treatmentNihad A M Tamimi
Nephron. Clinical Practice|September 5, 2009
Drug development: from concept to marketing!Nihad A M Tamimi, Peter Ellis
BJU International|February 27, 2010
A placebo-controlled study investigating the efficacy and safety of the phosphodiesterase type 5 inhibitor UK-369,003 for the treatment of men with lower urinary tract symptoms associated with clinical benign prostatic hyperplasiaNihad A M Tamimi, Ivan Mincik, Scott Haughie, et al.
BJU International|February 16, 2010
A placebo-controlled exploratory study investigating the efficacy and safety of the phosphodiesterase type 5 inhibitor UK-369,003 for the treatment of men with storage lower urinary tract symptoms associated with a clinical diagnosis of overactive bladderFrancois A Giuliano, Janice Lamb, Anna Crossland, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Saudi Journal of Kidney Diseases and Transplantation : an Official Publication of the Saudi Center for Organ Transplantation, Saudi Arabia|August 8, 2007
Resistant hypertension: a methodological approach to diagnosis and treatmentNihad A M Tamimi
Nephron. Clinical Practice|September 5, 2009
Drug development: from concept to marketing!Nihad A M Tamimi, Peter Ellis
BJU International|February 27, 2010
A placebo-controlled study investigating the efficacy and safety of the phosphodiesterase type 5 inhibitor UK-369,003 for the treatment of men with lower urinary tract symptoms associated with clinical benign prostatic hyperplasiaNihad A M Tamimi, Ivan Mincik, Scott Haughie, et al.
BJU International|February 16, 2010
A placebo-controlled exploratory study investigating the efficacy and safety of the phosphodiesterase type 5 inhibitor UK-369,003 for the treatment of men with storage lower urinary tract symptoms associated with a clinical diagnosis of overactive bladderFrancois A Giuliano, Janice Lamb, Anna Crossland, et al.
Pageof 1